Potential benefit of dehydroepiandrosterone supplementation for infertile but not poor responder patients in a IVF program.

Tartagni, M; De Pergola, G; Damiani, G R; Pellegrino, A; Baldini, D; Tartagni, M V; Alrasheed, H; De Salvia, M A; Loverro, G

Tartagni, M; De Pergola, G; Damiani, G R; Pellegrino, A; Baldini, D; Tartagni, M V; Alrasheed, H; De Salvia, M A; Loverro, G.

Affiliation

Tartagni M; Dimo gynecology and Pharmacology Section University of Bari, Policlinico, Bari, Italy - damiani14@alice.it.

Minerva Ginecol ; 67(1): 7-12, 2015 Feb.

Article in En | MEDLINE | ID: mdl-24867068

Subject(s)

Dehydroepiandrosterone/administration & dosage; Fertilization in Vitro/methods; Infertility, Female; Pregnancy Outcome; Abortion, Spontaneous/epidemiology; Adult; Chorionic Gonadotropin/blood; Double-Blind Method; Female; Humans; Oocytes/metabolism; Ovarian Reserve/physiology; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Outcome / Fertilization in Vitro / Dehydroepiandrosterone / Infertility, Female Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Minerva Ginecol Year: 2015 Document type: Article Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links